News
Carbon

CARBON Newsletter (28 January 2025) - Your Latest News About CRISPR in AgroBio

Some of the best links we picked up around the internet

By: Gorm Palmgren - Jan. 28, 2025
News

CRISPR AgroBio News (CARBON) - an emerging initiative from CRISPR Medicine News - has been hibernating for two years, but now we are back on track again.

CARBON will bring you the latest news on how CRISPR can shape agriculture for the future to guarantee food security in times of population growth and climate change.

To get more CRISPR AgroBio News delivered to your inbox, sign up to the free weekly CARBON Newsletter here.

Top picks

Technical advances

Disease and stress control

Agronomic traits

Industry

Detection

Commentaries and perspectives

  • According to a blog post on the ISAAA website, 2024 brought significant strides globally to gene editing, with crops like high-protein soybeans, disease-resistant wheat, and reduced-lignin maize gaining approvals and field trials. Countries including Thailand, Uruguay, and New Zealand updated regulations to support genome-edited crops, while the EU confirmed the safety of new genomic techniques. These advancements highlight gene editing’s growing role in sustainable agriculture and global food security.
  • To ensure food security amidst the growing challenges of climate change, a new study proposes two primary strategies to improve crops’ abiotic stress tolerance: "rewilding" domesticated crops by reintroducing stress tolerance genes lost during domestication and de novo domestication of resilient wild plants. The study underscores that both strategies face technical and societal barriers, including the need for policy reforms to streamline gene-editing regulations and broader public acceptance of genetically engineered crops.
  • An article in Food Engineering Magazine examines the regulatory and patent challenges surrounding CRISPR gene editing in agriculture, highlighting its potential to sustainably boost crop production while addressing environmental and food security issues. It explores the distinction between gene-edited and genetically modified crops, the complex global patent landscape, and differing regulatory frameworks across countries, emphasising the need for adaptive strategies to advance CRISPR’s adoption in agriculture.
  • A feature in Seed World finds that legal complexities surrounding CRISPR-Cas9 patents are complicating its commercial use, with disputes among key players like the Broad Institute, UC Berkeley, and ToolGen affecting access and licensing globally. Calgary-based AgGene is navigating this uncertain landscape while seeking licensing for its gene editing platform, balancing costs, efficiency, and long-term IP considerations. Canada’s evolving CRISPR patent system exemplifies how these disputes influence biotech innovation and accessibility.

Reviews

Conferences

  • The 7th CRISPR AgBio Congress will be held on 4-6 February 2025 in Raleigh, NC, focusing on cutting-edge gene editing for agriculture. Key themes include CRISPR advancements, delivery systems, regulatory pathways, commercialisation, and consumer acceptance. Sessions highlight innovations in crop resilience, biocontrol, and product development, showcasing strategies to accelerate gene-edited products while addressing sustainability and global food security challenges.

Tags

HashtagArticleHashtagNewsHashtagCARBONHashtagCARBON Newsletter

News: CARBON Newsletter (28 January 2025) - Your Latest News About CRISPR in AgroBio
CLINICAL TRIALS
Systemic Lupus Erythematosus, SLE, (NCT06752876)
Sponsors:
Caribou Biosciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Chronic Hepatitis B, HBV, (NCT06671093)
Sponsors:
Tune Therapeutics, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine